338 related articles for article (PubMed ID: 33998868)
1. Patterns of Medical Cannabis Use Among Older Adults from a Cannabis Dispensary in New York State.
Kaufmann CN; Kim A; Miyoshi M; Han BH
Cannabis Cannabinoid Res; 2022 Apr; 7(2):224-230. PubMed ID: 33998868
[No Abstract] [Full Text] [Related]
2. Patterns of Medical Cannabis Use among Cancer Patients from a Medical Cannabis Dispensary in New York State.
Kim A; Kaufmann CN; Ko R; Li Z; Han BH
J Palliat Med; 2019 Oct; 22(10):1196-1201. PubMed ID: 30909786
[No Abstract] [Full Text] [Related]
3. Analysis of Dispensing and Utilization Patterns of Medical Cannabis Products in State Licensed Cannabis Dispensaries.
Tanco K; Olson A; Fellman B; Jankowski M; Lai SY; Shete S; Harbison K; Scheid J; Bruera E
J Palliat Med; 2023 Nov; 26(11):1482-1487. PubMed ID: 37285183
[No Abstract] [Full Text] [Related]
4. Cannabis-based medicines for chronic neuropathic pain in adults.
Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392
[TBL] [Abstract][Full Text] [Related]
5. Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related Trends.
Lyu X; Illamola SM; Marino SE; Leppik IE; Dahmer S; Lehfeldt P; Conway JM; Remmel RP; Kingsley K; Birnbaum AK
Curr Ther Res Clin Exp; 2023; 99():100709. PubMed ID: 37538850
[TBL] [Abstract][Full Text] [Related]
6. Consumer Experiences with Delta-8-THC: Medical Use, Pharmaceutical Substitution, and Comparisons with Delta-9-THC.
Kruger DJ; Kruger JS
Cannabis Cannabinoid Res; 2023 Feb; 8(1):166-173. PubMed ID: 34797727
[No Abstract] [Full Text] [Related]
7. Can we predict the treatment doses of THC and CBD and does it matter?
Halamish N; Schleider LB; McGuire S; Novack V
Eur J Intern Med; 2023 Jun; 112():100-108. PubMed ID: 37003923
[TBL] [Abstract][Full Text] [Related]
8. Use and caregiver-reported efficacy of medical cannabis in children and adolescents in Switzerland.
Zürcher K; Dupont C; Weber P; Grunt S; Wilhelm I; Eigenmann DE; Reichmuth ML; Fankhauser M; Egger M; Fenner L
Eur J Pediatr; 2022 Jan; 181(1):335-347. PubMed ID: 34309706
[TBL] [Abstract][Full Text] [Related]
9. Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20).
Lintzeris N; Mills L; Abelev SV; Suraev A; Arnold JC; McGregor IS
Harm Reduct J; 2022 Jul; 19(1):88. PubMed ID: 35907959
[TBL] [Abstract][Full Text] [Related]
10. Authorization Patterns, Safety, and Effectiveness of Medical Cannabis in Quebec.
Kalaba M; MacNair L; Peters EN; Eglit GML; Rapin L; Hage CE; Prosk E; Ware MA
Cannabis Cannabinoid Res; 2021 Dec; 6(6):564-572. PubMed ID: 33998902
[No Abstract] [Full Text] [Related]
11. Investigating sex differences in acute intoxication and verbal memory errors after ad libitum cannabis concentrate use.
Gibson LP; Gust CJ; Ellingson JM; YorkWilliams SL; Sempio C; Klawitter J; Bryan AD; Hutchison KE; Cinnamon Bidwell L
Drug Alcohol Depend; 2021 Jun; 223():108718. PubMed ID: 33866072
[TBL] [Abstract][Full Text] [Related]
12. A Large-Scale Naturalistic Examination of the Acute Effects of Cannabis on Pain.
Cuttler C; LaFrance EM; Craft RM
Cannabis Cannabinoid Res; 2022 Feb; 7(1):93-99. PubMed ID: 33998864
[No Abstract] [Full Text] [Related]
13. Mapping cannabis potency in medical and recreational programs in the United States.
Cash MC; Cunnane K; Fan C; Romero-Sandoval EA
PLoS One; 2020; 15(3):e0230167. PubMed ID: 32214334
[TBL] [Abstract][Full Text] [Related]
14. The Association between Cannabis Product Characteristics and Symptom Relief.
Stith SS; Vigil JM; Brockelman F; Keeling K; Hall B
Sci Rep; 2019 Feb; 9(1):2712. PubMed ID: 30804402
[TBL] [Abstract][Full Text] [Related]
15. What Do You Know About Maryjane? A Systematic Review of the Current Data on the THC:CBD Ratio.
Zeyl V; Sawyer K; Wightman RS
Subst Use Misuse; 2020; 55(8):1223-1227. PubMed ID: 32124675
[No Abstract] [Full Text] [Related]
16. Cannabinoid Profiles in Medical Cannabis Users: Effects of Age, Gender, Symptoms, and Duration of Use.
Kalaba M; Ware MA
Cannabis Cannabinoid Res; 2022 Dec; 7(6):840-851. PubMed ID: 33999649
[No Abstract] [Full Text] [Related]
17. Ask Your Provider About Cannabis: Increasing Nurse Practitioner Knowledge and Confidence.
Klein TA; Bindler R
Cannabis Cannabinoid Res; 2022 Oct; 7(5):700-705. PubMed ID: 34432530
[No Abstract] [Full Text] [Related]
18. Chemical profiling of Cannabis varieties cultivated for medical purposes in southeastern Brazil.
Carvalho VM; de Almeida FG; de Macêdo Vieira AC; Rocha ED; Cabral LM; Strongin RM
Forensic Sci Int; 2022 Jun; 335():111309. PubMed ID: 35462181
[TBL] [Abstract][Full Text] [Related]
19. Ultra-high-performance liquid chromatography-tandem mass spectrometry assay for quantifying THC, CBD and their metabolites in hair. Application to patients treated with medical cannabis.
Lo Faro AF; Venanzi B; Pilli G; Ripani U; Basile G; Pichini S; Busardò FP
J Pharm Biomed Anal; 2022 Aug; 217():114841. PubMed ID: 35636009
[TBL] [Abstract][Full Text] [Related]
20. Impact of marijuana legalization on cannabis-related visits to the emergency department.
Tolan NV; Terebo T; Chai PR; Erickson TB; Hayes BD; Uljon SN; Petrides AK; Demetriou CA; Melanson SEF
Clin Toxicol (Phila); 2022 May; 60(5):585-595. PubMed ID: 34935567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
